Exosomal microRNA expression profiles derived from A549 human lung cells in response to influenza A/H1N1pdm09 infection
Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Tao Wu(Chinese Academy of Sciences), Kang Liu(Zhejiang Chinese Medical University), Bin Wu(Jiangsu Provincial Center for Disease Control and Prevention), Qiao Qiao(First Hospital of China Medical University), Ying Chi(China Three Gorges University), Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Xiaojuan Zhu(East China University of Science and Technology)
Cited by 10
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow
|The Journal of Experimental Medicine|2015|245